PT  - JOURNAL ARTICLE
AU  - Dwivedi, Alok K.
AU  - Jang, David
AU  - Belkin, Ofek
AU  - Aickareth, Justin
AU  - Renteria, Mellisa
AU  - Hawwar, Majd
AU  - Jacob, Croft
AU  - Kalas, M Ammar
AU  - Zuckerman, Marc J.
AU  - Zhang, Jun
TI  - Metabolic syndrome and hemorrhagic stroke among symptomatic CCMs in the Mexican Hispanic Population
AID  - 10.1101/2023.05.15.23289984
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.05.15.23289984
4099  - http://medrxiv.org/content/early/2023/05/16/2023.05.15.23289984.short
4100  - http://medrxiv.org/content/early/2023/05/16/2023.05.15.23289984.full
AB  - Cerebral cavernous malformations (CCMs) are neurological disorders that make individuals more susceptible to hemorrhagic stroke. The Mexican-Hispanic population has a higher prevalence of both CCMs and metabolic syndrome (MetS), which is also associated with hemorrhagic stroke. A study was conducted with 184 Mexican-Hispanic CCM subjects and age- and sex-matched Hispanic and non-Hispanic white controls. The CCM cohort had a higher proportion of epilepsy and hemorrhagic stroke but a lower proportion of MetS. Higher blood pressure and fasting glucose levels were observed in the CCM cohort. MetS and epilepsy were associated with increased odds of hemorrhagic stroke among elderly CCM patients, and increased systolic blood pressure was significantly linked to increased odds of hemorrhagic stroke in the CCM cohort. To minimize the risk of hemorrhagic stroke, it is important to manage blood pressure and comorbidities like MetS and epilepsy in CCM patients, particularly those older than 50.What is already known about this subjectMetabolic Syndrome (MetS) is widely associated with cardiovascular conditions, including stroke,The association between MetS and ischemic stroke is well establishedThe relationship between MetS and hemorrhagic stroke remains unclearCurrently, one two studies explored the relationship between MetS and hemorrhagic stroke in CCM patients; one n sporadic CCM (sCCM) and one in familial CCM cases, with inconsistent results.What are the new findingsIn this study, a strong association was observed between systolic blood pressure (SBP) and hemorrhagic stroke in the CCM cohort, independent of obesity or fasting glucose levels.This study also suggests that MetS is associated with hemorrhagic stroke among CCM patients, specifically in the older age group.How might it impact on clinical practice in the foreseeable futureThis study demonstrates many of the unique characteristics of symptomatic CCMs within the Mexican-Hispanic populationOur results suggests that of Mexican-Hispanic CCM subjects are at a greater risk for hemorrhagic stroke and epilepsy than other ethnic groups.This study highlights the importance of reducing blood pressure and managing comorbidities such as MetS and epilepsy in CCM patients, especially those who are older than 50 years to minimize the risk of hemorrhagic stroke among CCM subjectsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review board (IRB) at Texas Tech University Health Sciences Center El Paso (TTUHSCEP). This study was conducted in accordance with an approved protocol (E22031) from the institutional review board (IRB) at Texas Tech University Health Sciences Center El Paso (TTUHSCEP)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.